Assessing Takeda Pharmaceutical (TSE:4502) Valuation After Strong Multi‑Period Shareholder Returns
Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million individual investors worldwide.
Takeda Pharmaceutical (TSE:4502) has drawn fresh attention after a period where its share price total return is 0.3% over the past 3 months and 15.4% year to date, set against mixed shorter term moves.
Over the past month, the stock shows a 1.1% gain, with a flat 1 day move and a slight 0.2% decline over the past week, while the 1 year total return stands at 33.8% and the 3 year total return at 47.5%.
The company reports revenue of ¥4.46b and net income of ¥112,926, with annual revenue growth of 1.6% and annual net income growth of 23.3%, offering investors a snapshot of its current scale and recent earnings trend.
Takeda operates across gastroenterology, rare diseases, plasma derived therapies, immunology, oncology and neuroscience, supported by a broad portfolio that includes Entyvio, Takhzyro, Ninlaro and other branded products, as well as multiple collaboration and licensing agreements worldwide.
The current share price of ¥5,673.0 sits alongside a 90 day share price return of 27.54% and a 1 year total shareholder return of 33.82%, indicating that momentum has been present over both shorter and longer periods as investors reassess growth prospects and risk.
If Takeda’s move has you considering where the next opportunity might come from, this could be a good moment to review our list of 7 healthcare AI stocks for more healthcare related ideas with an AI angle.
With Takeda posting steady gains and trading close to its analyst price target, the key question for you is whether the current valuation still offers upside or whether the market is already pricing in future growth.
The most followed narrative puts Takeda’s fair value at ¥5,590, which sits slightly below the last close of ¥5,673. That small gap relates to how future growth and margins are expected to play out.
Rapid progress and positive late-stage data from Takeda’s pipeline, especially in high-need therapeutic areas like rare diseases (orexin agonists for narcolepsy, rusfertide for polycythemia vera), set the stage for multiple high-value product launches, which can catalyze multi-year revenue and margin expansion.
If you are curious what kind of earnings change, margin shift and future P/E this narrative is based on, and how that ties back to today’s price, the full story lays out those assumptions in detail so you do not have to piece them together yourself.
However, this depends on legal and execution risks, with the Actos class action and potential pipeline setbacks both capable of sharply changing how the story unfolds.
While the AI narrative frames Takeda as 1.5% overvalued around a fair value of ¥5,590, our DCF model comes out in a very different place, with an estimate of future cash flow value at ¥14,744.38 per share, suggesting the current price of ¥5,673 is 61.5% below that level.
That gap reflects how sensitive long term cash flow assumptions and discounting can be compared with earnings based views. The real question for you is which set of assumptions you find more realistic, and how much of that upside or downside risk you are comfortable owning.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Takeda Pharmaceutical for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 23 high quality undervalued stocks. If you save a screener we even alert you when new companies match – so you never miss a potential opportunity.
With mixed signals on value and sentiment, this is a moment to look under the hood yourself and act while the information is fresh, starting with 2 key rewards and 4 important warning signs.
If Takeda has sharpened your focus, do not stop here. Broaden your watchlist with other ideas that fit different goals and risk levels.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include 4502.T.
HYDERABAD, India, March 17, 2026 /PRNewswire/ — According to the latest report by Mordor Intelligence, the rolling stock market size is progressing steadily, growing from USD 33.97 billion in 2025 to USD 35.25 billion in 2026, and is projected to reach USD 42.44 billion by 2031, at a CAGR of 3.78% during 2026–2031. Growth is primarily
For more than three years, the rise of artificial intelligence (AI) has captured the attention and capital of investors. Analysts at PwC foresee this technology creating more than $15 trillion in global economic value by the turn of the decade. While Wall Street’s largest publicly traded company and the face of the artificial intelligence revolution,
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. The latest update to the Compañía Cervecerías Unidas model lifts the fair value estimate from CLP6,098.75 to CLP6,104.38, a small move that still matters if you are tracking price targets closely. Recent Street commentary, including
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for FREE. IDP Education’s fair value price target has shifted slightly, from A$6.80 to A$6.85, after recent adjustments to the valuation model. That modest move sits alongside a split in analyst views, with some highlighting long term potential
BANGKOK (AP) — Shares wavered in Asia on Tuesday after a drop in oil prices helped send the U.S. stock market to its best day since the war in Iran began. The reprieve in prices for crude was short-lived, with Brent crude climbing nearly 3% early Tuesday to $103.17 a barrel. U.S. benchmark crude also
Packaged foods company General Mills (NYSE:GIS) will be reporting results this Wednesday before market open. Here’s what investors should know. General Mills beat analysts’ revenue expectations last quarter, reporting revenues of $4.86 billion, down 7.2% year on year. It was a strong quarter for the company, with an impressive beat of analysts’ EBITDA estimates and
An investment in crypto company BitMine Immersion Technologies (BMNR +13.44%) is one of the top sideways plays on the value of Ethereum. So when the currency does well, as it has lately, investors tend to welcome any move BitMine makes to expand its holdings. Sure enough, the company’s regular Monday update indicated exactly that, and
The stock market is in choppy waters as the Iran war extends into its third week, but the shake-up is shedding light on some emerging opportunities, Goldman Sachs said. In a note to clients on Friday, strategists at the bank pointed to the recent stock-market volatility stemming from the US-Iran war, and said they saw
Warren Buffett once wrote about interest rates: “These act on financial valuations the way gravity acts on matter.” In other words, how much a stock is worth is directly affected by the risk-free rate investors can receive in the bond market. If they can get a higher risk-free return from U.S. Treasuries, investors aren’t going
Is the Great Software Stock Rout over? It’s too soon to say, but some titles in the category enjoyed a bit of a comeback Monday. One was ServiceNow (NOW +1.18%), a specialist in optimizing IT workflows in businesses. Investors traded the company up by more than 1.1%, which was just good enough to beat the
While Nvidia (NASDAQ: NVDA) has dominated the conversation as the top artificial intelligence (AI) computing unit provider for years, Broadcom (NASDAQ: AVGO) is becoming a force to be reckoned with. Broadcom’s approach to AI computing is more specialized than Nvidia’s, but with AI workloads starting to become more mature, this specialized approach is gaining momentum.
Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Building materials group CRH is leaving the London Stock Exchange entirely, dealing another setback to the UK’s position as an equities trading hub. The move comes two-and-a-half years after CRH moved its primary listing to
Toronto, Ontario–(Newsfile Corp. – March 16, 2026) – New Break Resources Ltd. (CSE: NBRK) (FSE: O91) (“New Break” or the “Company“) is pleased to announce that its common shares have been cross-listed on the Frankfurt Stock Exchange (“FSE“) in Germany under the symbol FSE: O91 effective March 13, 2026. The Company’s common shares will continue
“History doesn’t repeat itself, but it often rhymes.” There’s a debate over the exact wording of this quote and who said it first. However, the adage’s premise is spot on. While current events are never completely similar to those in the past, they can be eerily similar. I think we’re seeing this firsthand right now.
The S&P 500 (^GSPC +0.97%) is widely regarded as the best benchmark for the U.S. stock market because it covers about 80% of domestic equities by market value. The index is currently 5% below its record high after falling in three straight weeks. Several factors have contributed to the drawdown: President Trump’s tariffs have coincided
Few quarterly data releases are more valuable to investors than the filing of Form 13Fs with the Securities and Exchange Commission. A 13F allows investors to track which stocks Wall Street’s prominent money managers bought and sold in the latest quarter (in this instance, the fourth quarter). Billionaire investor Dan Loeb of Third Point certainly
Few trends have had as much influence on the stock market over the last few years as artificial intelligence (AI). Fears of generative AI-powered solutions displacing established enterprise software providers have led to a massive sell-off in SaaS stocks. Meanwhile, investors fear the big capital expenditure budgets of the U.S. hyperscalers may be excessive and
ETFGI reported that assets invested in the ETFs industry in the United States reached a new record of US$14.28 trillion at the end of February. During February, the ETFs industry in the United States gathered net inflows of US$192.25 billion, bringing year-to-date net inflows to US$358.90 billion, according to ETFGI’s February 2026 US ETFs and
Artificial intelligence (AI) stock investors have earned massive returns. The best-performing stocks succeeded because they built a competitive advantage that other companies could not easily match, if they could match at all. This means the industry has produced several winners, and that makes choosing the “best” one to succeed the most difficult. Nonetheless, that designation
📌 Top story — scroll down for more updates JD.com Launches Joybuy to Rival Amazon in UK 8:00 am — JD +0.64%, AMZN +0.48% in pre-market trading JD.com (JD +2.47%) has officially launched its Joybuy marketplace across the UK and Northern Europe, signaling a direct assault on Amazon‘s (AMZN +0.47%) regional dominance. Leveraging its $2.5
